Monthly Archive: July 2014

Jul 24

Gilead Cashing In On Hepatitis C Cure

San Francisco-based Gilead Sciences Inc. has seen its second quarter results benefit from sales of Sovaldi – to the tune of $5.8 billion. The launch of Sovaldi, a treatment for Hepatitis C with a claimed cure rate of 90% and fewer side effects than previously available treatments, was highly anticipated by patients and medical professionals …

Continue reading »

Jul 23

Apple Granted Patent for a Device Named iTime

Apple was on Tuesday awarded a patent for the ‘iTime” device by the United States Patent and Trademark Office. This adds evidence to the speculation that Apple is developing a smartwatch. The patent does not reveal much information about Apple’s plans. The patent describes an electronic device to be worn by the user that will …

Continue reading »